ESR1 mutations are similarly prevalent in newly metastatic and loco-regional recurrence of endocrine-treated breast cancer patients and carry worse prognosis

Autor:	E. Nili Gal Yam, S. Kahana, Adi Zundelevich, Maya Dadiani, Bella Kaufman, Iris Barshack, Tal Sela, Moran Gadot, Amit Itay, Anya Pavlovsky
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Breast cancer business.industry Internal medicine Mutation (genetic algorithm) medicine Endocrine system Hematology business medicine.disease Estrogen receptor alpha
Zdroj:	Annals of Oncology. 30:iii8
ISSN:	0923-7534
DOI:	10.1093/annonc/mdz095.021
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ce7c01d202d32e7fe812eb639ea4698c https://doi.org/10.1093/annonc/mdz095.021 Zobrazit plný text záznamu